SCC
CMD

Spring Creek Capital’s Cantel Medical Corporation CMD Stock Holding History

Spring Creek Capital’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-8,819
Closed -$867K – 768
2018
Q2 		$867K Buy
+8,819
New +$986K 0.1% 180

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Spring Creek Capital's CMD Position: Q3 2018 in Review

Spring Creek Capital sold out of Cantel Medical Corporation (CMD) in Q3 2018, closing a stake of 8,819 shares — an estimated $867K sold.

Spring Creek Capital first reported a position in CMD in Q2 2018 and held it in 1 quarter. The position peaked at $867K in Q2 2018. 286 funds tracked by Wall St. Rank hold CMD as of Q3 2018.

  • Spring Creek Capital reported no remaining Cantel Medical Corporation position as of Q3 2018 after selling out during the quarter.
  • Spring Creek Capital sold 8,819 Cantel Medical Corporation shares in Q3 2018, an estimated $867K.
  • Spring Creek Capital first reported a position in Cantel Medical Corporation in Q2 2018 and held it in 1 quarter.
  • Spring Creek Capital's Cantel Medical Corporation position peaked at $867K in Q2 2018.
  • 286 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2018.

Based on Spring Creek Capital's 13F filing for Q3 2018, filed 13 Nov 2018.